Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Mackinnon

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Blood|January 22, 2011
Families get mobilized to treat AMLStephen Mackinnon, Ronjon Chakraverty
The New England Journal of Medicine|March 15, 2003
Imatinib mesylate--the new gold standard for treatment of chronic myeloid leukemiaKarl Peggs, Stephen Mackinnon
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 2, 2005
Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL)Emma Morris, Stephen Mackinnon
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Relapsed AML post-allogeneic hematopoietic stem cell transplantationEmma Nicholson, Stephen Mackinnon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Allogeneic transplantation for lymphomaRonjon Chakraverty, Stephen Mackinnon
Human Immunology|June 3, 2004
Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapyKarl S Peggs, Stephen Mackinnon
The International Journal of Biochemistry & Cell Biology|April 10, 2004
Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantationKarl S Peggs, Stephen Mackinnon
Best Practice & Research. Clinical Haematology|February 8, 2005
Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphomaEmma C Morris, Stephen Mackinnon
British Journal of Haematology|February 27, 2004
Immune reconstitution following haematopoietic stem cell transplantationKarl S Peggs, Stephen Mackinnon
Hematology (Amsterdam, Netherlands)|September 24, 2002
Adoptive cellular therapy: a therapeutic reality?Karl S Peggs, Stephen Mackinnon
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Blood|January 22, 2011
Families get mobilized to treat AMLStephen Mackinnon, Ronjon Chakraverty
The New England Journal of Medicine|March 15, 2003
Imatinib mesylate--the new gold standard for treatment of chronic myeloid leukemiaKarl Peggs, Stephen Mackinnon
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 2, 2005
Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL)Emma Morris, Stephen Mackinnon
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Relapsed AML post-allogeneic hematopoietic stem cell transplantationEmma Nicholson, Stephen Mackinnon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Allogeneic transplantation for lymphomaRonjon Chakraverty, Stephen Mackinnon
Human Immunology|June 3, 2004
Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapyKarl S Peggs, Stephen Mackinnon
The International Journal of Biochemistry & Cell Biology|April 10, 2004
Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantationKarl S Peggs, Stephen Mackinnon
Best Practice & Research. Clinical Haematology|February 8, 2005
Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphomaEmma C Morris, Stephen Mackinnon
British Journal of Haematology|February 27, 2004
Immune reconstitution following haematopoietic stem cell transplantationKarl S Peggs, Stephen Mackinnon
Hematology (Amsterdam, Netherlands)|September 24, 2002
Adoptive cellular therapy: a therapeutic reality?Karl S Peggs, Stephen Mackinnon
Pageof 11